| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 2.7B | +2% |
| Gross Profit | 569.9MM | +6% |
| Cost Of Revenue | 2.1B | +2% |
| Operating Income | 60MM | - |
| Operating Expenses | 509.9MM | - |
| Net Income | 17.8MM | -377% |
| G&A | 457.2MM | +1% |
| Amortization | 20.9MM | +0% |
| Interest Expense | 36.9MM | -3% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
RICHMOND, Va., April 22, 2024--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the first quarter of 2024 on Friday, May 3, 2024, before trading begins on the New York Stock Exchange.
In this article, we will take a detailed look at Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024. For a quick overview of such stocks, read our article Jim Cramer’s 5 Favorite Healthcare Stock Picks in 2024. Jim Cramer kicked off 2024 with a positive note for the healthcare sector, saying in a program in January that the […]
Owens & Minor (OMI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Owens & Minor, Inc. (NYSE:OMI) Q4 2023 Earnings Call Transcript February 20, 2024 Owens & Minor, Inc. beats earnings expectations. Reported EPS is $0.69, expectations were $0.68. OMI isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day. And thank […]
Q4 2023 Owens & Minor Inc Earnings Call
Owens & Minor Inc (NYSE OMI) reported fourth-quarter 2023 adjusted EPS of $0.69, up from $0.28 a year ago and beating the consensus of $0.66. Revenues increased 4% year-on-year (Y/Y) to $2.66 billion, in line with the consensus. Patient Direct revenue of $664 million increased 8% Y/Y from strong growth in several product categories. Products & Healthcare Services revenue of nearly $2 billion, up 3% compared to the fourth quarter of 2022, with growth in both the Medical Distribution and Global Pr
Owens & Minor (OMI) delivered earnings and revenue surprises of 1.47% and 0.26%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
OMI's Focused Execution Drives Revenue Growth and Robust Cash Flow Generation
RICHMOND, Va., February 20, 2024--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2023.